Skip to content

Clinical trials

Observational Ischemic Stroke trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Observational Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20121
20131
20141
20163
20174
20182
20191
20214
20223
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting6
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alberta4
Canadian Network for Observational Drug Effect Studies, CNODES3
Stryker Neurovascular2
Amelie Belanger1
Canadian Medical and Surgical Knowledge Translation Research Group1
Carol Kenney1
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec1
Insel Gruppe AG, University Hospital Bern1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Luciano A. Sposato1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke24
Stroke6
Atrial Fibrillation4
Ischemic Attack, Transient4
Myocardial Infarction3
Cardiovascular Diseases2
Cerebral Hemorrhage2
Cerebrovascular Disorders2
Diabetes Mellitus, Type 22
Inflammation2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.